Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ANI Pharmaceuticals, Inc. - Common Stock (NQ:ANIP)

94.79 +2.84 (+3.09%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ANI Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
Recap: ANI Pharmaceuticals Q2 Earnings
Shares of ANI Pharmaceuticals (NASDAQ:ANIP) were unchanged after the company reported Q2 results. Quarterly Results Earnings per share fell 2.90% year over year to $0.67,... 
Via Benzinga
ANI Pharmaceuticals Reports Second Quarter 2021 Results
From ANI Pharmaceuticals, Inc.
Via Business Wire
Earnings Scheduled For August 6, 2021
Companies Reporting Before The Bell • Liberty Braves Group (NASDAQ:BATRA) is projected to report quarterly loss at $0.03 per share on revenue of $154.00 million.... 
Via Benzinga
The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)... 
Via Benzinga
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... 
Via Benzinga
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results.... 
Via Benzinga
ANI Pharmaceuticals to Discuss Second Quarter 2021 Financial Results on August 6, 2021
From ANI Pharmaceuticals, Inc.
Via Business Wire
ANI Pharmaceuticals Announces Refiling of Cortrophin sNDA with FDA
From ANI Pharmaceuticals, Inc.
Via Business Wire
ANI Pharmaceuticals to Present at the Raymond James Human Health Innovation Conference 2021
From ANI Pharmaceuticals, Inc.
Via Business Wire
ANI Pharmaceuticals Announces Details of 2021 Virtual Annual Meeting of Stockholders
From ANI Pharmaceuticals, Inc.
Via Business Wire
ANI Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference 2021
From ANI Pharmaceuticals, Inc.
Via Business Wire
ANI Pharmaceuticals Inc (ANIP) Q1 2021 Earnings Call Transcript
ANIP earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
ANI Pharmaceuticals Reports First Quarter 2021 Results
From ANI Pharmaceuticals, Inc.
Via Business Wire
Earnings Outlook for ANI Pharmaceuticals
On Friday, May 07, ANI Pharmaceuticals (NASDAQ:ANIP) will release its latest earnings report. Here is Benzinga's outlook for the company. What Are Earnings, Net Income, And... 
Via Benzinga
ANI Pharmaceuticals to Discuss First Quarter 2021 Financial Results on May 7, 2021
From ANI Pharmaceuticals, Inc.
Via Business Wire
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:... 
Via Benzinga
Earnings Scheduled For May 7, 2021
Companies Reporting Before The Bell • Cronos Group (NASDAQ:CRON) is likely to report earnings for its first quarter. • Eaton Vance Municipal (NYSE:ETX) is... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.